A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

NCT00515437 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Drooling

Interventions

BIOLOGICAL: Botulinum Toxin Type B (Myobloc)
BIOLOGICAL: Matched placebo to Myobloc

Sponsor

Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC